Cargando…

Construction and Immunogenicity of a Recombinant Pseudorabies Virus Expressing SARS-CoV-2-S and SARS-CoV-2-N

Coronavirus (CoV) is an important pathogen of humans and animals, which can infect humans or animals through the respiratory mucosal route. Syndrome coronavirus 2 (SARS-CoV-2) is quite similar to syndrome coronavirus (SARS-CoV) with the same receptor, angiotensin-converting enzyme 2 (ACE2). The S an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ruoying, Shao, Guanming, Xie, Zi, Hu, Zezhong, Feng, Keyu, He, Jiahui, Wang, Hailong, Fu, Jun, Zhang, Xinheng, Xie, Qingmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380597/ https://www.ncbi.nlm.nih.gov/pubmed/35982925 http://dx.doi.org/10.3389/fvets.2022.920087

Ejemplares similares

Construction and Evaluation of Recombinant Pseudorabies Virus Expressing African Swine Fever Virus Antigen Genes
por: Chen, Liyi, et al.
Publicado: (2022)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

An Overview of SARS-CoV-2 and Animal Infection
por: Mahdy, Mohamed A. A., et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Analysis of Possible Intermediate Hosts of the New Coronavirus SARS-CoV-2
por: Yuan, Shu, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Dogs and Cats: Facts and Speculations
por: Decaro, Nicola, et al.
Publicado: (2021)

Serological survey of SARS-CoV-2 in companion animals in China
por: Wang, Aiping, et al.
Publicado: (2022)

Contribution of cats and dogs to SARS-CoV-2 transmission in households
por: Fischer, Egil A. J., et al.
Publicado: (2023)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021)

Evaluation of SARS-CoV-2 identification methods through surveillance of companion animals in SARS-CoV-2-positive homes in North Carolina, March to December 2020
por: Gin, Taylor E., et al.
Publicado: (2023)

Development of an Indirect ELISA for the Detection of SARS-CoV-2 Antibodies in Cats
por: Bold, Dashzeveg, et al.
Publicado: (2022)

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
por: Lyke, Kirsten E., et al.
Publicado: (2023)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
por: Kakkassery, Helen, et al.
Publicado: (2022)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats
por: Tabynov, Kairat, et al.
Publicado: (2022)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

“Sniffing” out SARS-CoV-2 in Arizona working dogs: an exploratory serosurvey
por: Hecht, Gavriella, et al.
Publicado: (2023)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)

Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
por: Bhardwaj, Taniya, et al.
Publicado: (2023)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer
por: Denault, Elyssa, et al.
Publicado: (2022)

Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light
por: Gracheva, A. V., et al.
Publicado: (2022)

Double insult: flu bug enhances SARS-CoV-2 infectivity
por: Su, Shan, et al.
Publicado: (2021)

SARS-CoV-2 Nucleocapsid Protein Has DNA-Melting and Strand-Annealing Activities With Different Properties From SARS-CoV-2 Nsp13
por: Zhang, Bo, et al.
Publicado: (2022)

SARS-CoV-2
por: Steinbauer, M., et al.
Publicado: (2020)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
por: Sohpal, Vipan Kumar
Publicado: (2020)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
por: Al-Salihi, Karima A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q0nm2lj9nupmg971jeln8nduum